المؤلفون: DePalo, Danielle K., Lee, Rachel M., Lopez‐aguiar, Alexandra G., Gamboa, Adriana C., Rocha, Flavio, Poultsides, George, Dillhoff, Mary, Fields, Ryan C., Idrees, Kamran, Nathan, Hari, Abbott, Daniel, Maithel, Shishir K., Russell, Maria C.

مصطلحات موضوعية: pancreas, neuroendocrine tumors, racial disparities, small bowel, lymph node positivity, Oncology and Hematology, Surgery and Anesthesiology, Health Sciences

وصف الملف: application/pdf

العلاقة: DePalo, Danielle K.; Lee, Rachel M.; Lopez‐aguiar, Alexandra G.; Gamboa, Adriana C.; Rocha, Flavio; Poultsides, George; Dillhoff, Mary; Fields, Ryan C.; Idrees, Kamran; Nathan, Hari; Abbott, Daniel; Maithel, Shishir K.; Russell, Maria C. (2019). "Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?." Journal of Surgical Oncology 120(6): 919-925.; https://hdl.handle.net/2027.42/151832Test; Journal of Surgical Oncology; Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005; 128: 1717 â 1751.; Hallet J, Law CHL, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a populationâ based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015; 121 ( 4 ): 589 â 597.; Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017; 19 ( 12 ): 991 â 1002.; Fraenkel M, Kim MK, Faggiano A, Valk GD. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012; 26 ( 3 ): 691 â 703.; Tsikitis VL, Wertheim BC, Guerrero MA. Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a SEER analysis. J Cancer. 2012; 3: 292 â 302.; Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017; 3 ( 10 ): 1335 â 1342.; Pasricha G, Padhi P, Daboul N, Monga DK. Management of wellâ differentiated gastroenteropancreatic neuroendocrine tumors (GEPNETs): a review. Clin Ther. 2017; 39 ( 11 ): 2146 â 2157.; Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008; 9 ( 1 ): 61 â 72.; Zaidi MY, Lopezâ Aguiar AG, Dillhoff M, et al. Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small bowel neuroendocrine tumors. JAMA Surg. 2019; 154 ( 2 ): 134 â 140.; Fraenkel M, Kim M, Faggiano A, de Herder W, Valk G. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014; 21 ( 3 ): R153 â R163.; Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of highâ volume hospitals for complex surgery. JAMA. 2006; 296 ( 16 ): 1973 â 1980.; Zhou H, Zhang Y, Wei X, et al. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer Med. 2017; 6 ( 11 ): 2745 â 2756.; St Julien J, Huo J, Shih YCT, et al. Impact of race on surgical management of pancreatic neuroendocrine tumors. J Clin Oncol. 2016; 34 ( 15 ): e18081 â e18081.; Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology. Cancer. 2008; 113: 2655 â 2664.

الإتاحة: https://doi.org/10.1002/jso.25662Test
https://hdl.handle.net/2027.42/151832Test

المؤلفون: Gamboa, Adriana C.¹ (AUTHOR), Maithel, Shishir K.¹ (AUTHOR) smaithe@emory.edu

المصدر: Journal of Gastrointestinal Surgery. Oct2020, Vol. 24 Issue 10, p2318-2335. 18p.

مصطلحات موضوعية: *CLINICAL trials, *SURGEONS, *PANCREAS, *GASTROINTESTINAL surgery, *PROCTOLOGY